Dr. Shalem’s research focuses on translational target discovery for a range of neurodegenerative diseases. He combines technology development of large-scale CRISPR-based perturbation screens with application of such technology together with additional genomic approaches.
Tom Curran, PhD, FRS, of The Children’s Hospital of Philadelphia Research Institute, contributed to an article in the Journal of Clinical Oncology assessing the efficacy of a drug called vismodegib (Erivedge) in a subgroup of patients with recurrent medulloblastoma.
The Children’s Hospital of Philadelphia Research Institute’s Office of Academic Training and Outreach Programs announced the selection of two new Research Administration fellows. Katherine Yang-Iott and Danika Johnston, PhD.
Researchers and physicians at The Children’s Hospital of Philadelphia are part of a transdisciplinary team that will apply sophisticated technology and methodology in molecular biology and genomics to help better understand the basis for preterm birth.